{"protocolSection":{"identificationModule":{"nctId":"NCT04325932","orgStudyIdInfo":{"id":"UK-001"},"organization":{"fullName":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"},"briefTitle":"Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis","officialTitle":"Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis: a Study Based on Whole-brain CTP"},"statusModule":{"statusVerifiedDate":"2015-05","overallStatus":"WITHDRAWN","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-05","type":"ACTUAL"},"completionDateStruct":{"date":"2019-07","type":"ACTUAL"},"studyFirstSubmitDate":"2017-10-05","studyFirstSubmitQcDate":"2020-03-27","studyFirstPostDateStruct":{"date":"2020-03-30","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-03-27","lastUpdatePostDateStruct":{"date":"2020-03-30","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether Urinary Kallikrein has an additional effect on enhancing collateral circulation in symptomatic intracranial atherosclerotic patients under clopidogrel and aspirin dual antiplatelet therapy."},"conditionsModule":{"conditions":["Intracranial Arteriosclerosis","Collateral Circulation","Anterior Cerebral Circulation Infarction"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"BASIC_SCIENCE","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Urinary Kallikrein group","type":"EXPERIMENTAL","description":"Urinary Kallikrein for injection, 0.15PNA IU,qd, for 2 weeks, administered within 96 hours after TIA or acute ischemic stroke, with basic therapies like dual antiplatelet therapy, blood pressure-lowering therapy and lipid-lowering therapy.","interventionNames":["Drug: Urinary Kallikrein"]},{"label":"control group","type":"NO_INTERVENTION","description":"with basic therapies like dual antiplatelet therapy, blood pressure-lowering therapy and lipid-lowering therapy."}],"interventions":[{"type":"DRUG","name":"Urinary Kallikrein","armGroupLabels":["Urinary Kallikrein group"],"otherNames":["Urinary Kallidinogenase"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"the percentage of patients with modified Rankin Score (mRS) equivalent to or less than 2","timeFrame":"3 months"}],"secondaryOutcomes":[{"measure":"rLMC scale of Collateral circulation","description":"We use regional leptomeningeal score(rLMC) score to measure collateral circulation.rLMC score is based on scoring pial and lenticulostriate arteries in 6 ASPECTS regions(M1-6) plus anterior cerebral artery region and basal ganglia. Pial arteries in the Sylvian sulcus are scored 0,2, or 4.","timeFrame":"2 weeks, 1 month"},{"measure":"NIHSS score","timeFrame":"2 weeks, 1month"},{"measure":"Hemorrhageic complications","description":"Hemorrhageic complications including intracranial, digestive tract","timeFrame":"2 weeks, 1 month, 3 months, 6 months"},{"measure":"New stroke or transient ischemic attack(TIA)","timeFrame":"6 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Acute ischemic stroke or TIA within 72 hours;\n2. Intracranial ICA, MCA M1 segment stenosis (\\>70%)\n\nExclusion Criteria:\n\n1. \\>70% Stenosis in an intracranial artery other than the culprit artery.\n2. \\>50% Stenosis of an extracranial carotid or vertebral artery on the ipsilateral side.\n3. Perforator strokes based on MRI.\n4. Non-atherosclerotic lesion, for example, moyamoya disease, vascular inflammatory disease due to infection, autoimmunity diseases, developmental or genetic abnormalities, for example, fibromuscular dysplasia, sickle-cell anaemia, suspected vasospasm.\n5. Potential cardiac embolism as cause.\n6. Intracranial haemorrhage within 6 weeks.\n7. Concomitant intracranial tumour, aneurysm or arteriovenous malformation.\n8. Known contraindications for heparin, aspirin, clopidogrel or contrast.\n9. Haemoglobin \\<10 g/dL, blood platelet count \\<100 000, international normalisation ratio \\>1.5, or other uncorrectable coagulopathies.Impaired liver function (alanine aminotransferase or glutamic oxalacetic transaminase ≥ 3×upper limit of normal) or renal function (serum creatinie ≥ 1.5mg/dl);\n10. A baseline modified Rankin Score of ≥3.\n11. Life expectancy of \\<1 year due to the concomitant illness.\n12. Pregnant or lactating women.\n13. long-term statins users.\n14. History of mental instability or dementia.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Min Lou, Ph.D,M.D.","affiliation":"second affiliated hospital of Zhejiang University, school of medicine","role":"STUDY_CHAIR"}],"locations":[{"facility":"The second affiliated hospital of Zhejiang University","city":"Hangzhou","state":"Zhejiang","zip":"310000","country":"China","geoPoint":{"lat":30.29365,"lon":120.16142}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000002537","term":"Intracranial Arteriosclerosis"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000050197","term":"Atherosclerosis"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000007238","term":"Infarction"}],"ancestors":[{"id":"D000007511","term":"Ischemia"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000020765","term":"Intracranial Arterial Diseases"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000020521","term":"Stroke"}],"browseLeaves":[{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M25878","name":"Atherosclerosis","asFound":"Atherosclerosis","relevance":"HIGH"},{"id":"M5476","name":"Intracranial Arteriosclerosis","asFound":"Intracranial Arteriosclerosis","relevance":"HIGH"},{"id":"M4159","name":"Arteriosclerosis","asFound":"Arteriosclerosis","relevance":"HIGH"},{"id":"M21995","name":"Brain Infarction","asFound":"Anterior Cerebral Circulation Infarction","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M22211","name":"Intracranial Arterial Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"BC10","name":"Nervous System Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000007610","term":"Kallikreins"}],"ancestors":[{"id":"D000003029","term":"Coagulants"},{"id":"D000005303","term":"Fertility Agents, Male"},{"id":"D000005299","term":"Fertility Agents"},{"id":"D000012102","term":"Reproductive Control Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M10328","name":"Kallikreins","asFound":"Homozygous Familial Hypercholesterolemia","relevance":"HIGH"},{"id":"M5949","name":"Coagulants","relevance":"LOW"}],"browseBranches":[{"abbrev":"Coag","name":"Coagulants"},{"abbrev":"Repr","name":"Reproductive Control Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}